A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant.
Saved in:
| Title: | A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant. |
|---|---|
| Authors: | Falloon, Judith1 FalloonJ@MedImmune.com, Ji, Fei1, Curtis, Craig2, Bart, Stephan3, Sheldon, Eric4, Krieger, Diane4, Dubovsky, Filip1, Lambert, Stacie5, Takas, Therese1, Villafana, Tonya1, Esser, Mark T.1 |
| Source: | Vaccine. May2016, Vol. 34 Issue 25, p2847-2854. 8p. |
| Database: | Environment Complete |
Be the first to leave a comment!
